drugset / Trial / NCT00070993

Creatine for the Treatment of Amyotrophic Lateral Sclerosis

NCT00070993

RandomizedFactorialDouble-blindTreatment

Summary

Creatine is a naturally occurring chemical involved in the production of energy in muscle. Abnormalities in creatine have been linked to the progression of degenerative neuromuscular diseases such as amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). This study will test whether taking creatine can improve the symptoms of ALS.

Timeline

Start
2002-12
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Creatine Other / unclassified